1. Benefit–Risk Assessment of Dabigatran in the Treatment of Stroke Prevention in Non-Valvular Atrial Fibrillation

   • Sascha Meyer dos Santos
   • Sebastian Harder

   Review Article 29 March 2014 Pages: 295 - 307

   

2. Comparative Safety and Efficacy of Proton Pump Inhibitors in Paediatric Gastroesophageal Reflux Disease

   • Jaroslaw Kierkus
   • Grzegorz Oracz
   • Marek Woynarowski

   Review Article 05 April 2014 Pages: 309 - 316

3. Impact of Interventions Designed to Reduce Medication Administration Errors in Hospitals: A Systematic Review

   • Richard N. Keers
   • Steven D. Williams
   • Darren M. Ashcroft

   Systematic Review 24 April 2014 Pages: 317 - 332

   

4. Managing Medicinal Risks in Self-Medication

   • Sylvie Fainzang

   Original Research Article 03 April 2014 Pages: 333 - 342

5. Digital Drug Safety Surveillance: Monitoring Pharmaceutical Products in Twitter

   • Clark C. Freifeld
   • John S. Brownstein
   • Nabarun Dasgupta

   Original Research Article Open access 29 April 2014 Pages: 343 - 350

   

6. A Comparison of the Effects of Different Typographical Methods on the Recognizability of Printed Drug Names

   • Calvin K. L. Or
   • Hailiang Wang

   Original Research Article 10 April 2014 Pages: 351 - 359

   

7. Fibrates and Risk of Cancer in Tissues with High PPAR-α Concentration: A Nested Case–Control Study

   • Francesco Salvo
   • Fabienne Bazin
   • Antoine Pariente

   Original Research Article 18 April 2014 Pages: 361 - 368

   

8. Adherence to Renal Function Monitoring Guidelines in Patients Starting Antihypertensive Therapy with Diuretics and RAAS Inhibitors: A Retrospective Cohort Study

   • Jan C. van Blijderveen
   • Sabine M. Straus
   • Katia M. Verhamme

   Original Research Article 19 April 2014 Pages: 369 - 377

   

9. Erratum to: Dose-Specific Adverse Drug Reaction Identification in Electronic Patient Records: Temporal Data Mining in an Inpatient Psychiatric Population

   • Robert Eriksson
   • Thomas Werge
   • Søren Brunak

   Erratum 09 April 2014 Pages: 379 - 379

10. Erratum to: The Weber Effect and the United States Food and Drug Administration’s Adverse Event Reporting System (FAERS): Analysis of Sixty-Two Drugs Approved from 2006 to 2010

    • Keith B. Hoffman
    • Mo Dimbil
    • Brian M. Overstreet

    Erratum 09 April 2014 Pages: 381 - 381